⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 2, 2024

Supplementary Figure 1 from Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors

Chirayu Mohindroo Seyda Baydogan Parul Agarwal R. D. Wright Laura R. Prakash Maureen E. Mork Alison P. Klein Daniel A. Laheru Jessica E. Maxwell Matthew H. G. Katz Arvind Dasari Michael P. Kim Jin He Florencia McAllister Ana De Jesus‐Acosta

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Supplementary Figure 1: Flow diagram showing the type of testing in both the cohorts.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mohindroo et al. (2024) studied this question.

synapsesocial.com/papers/68e61b6eb6db6435875adaac https://doi.org/10.1158/1940-6207.26145125

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 1 from Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors2024
2Data from Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors2024
3Supplementary Figure 1 from Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case–Control Study from the <i>All of Us</i> Research Program2025
4Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors2024 · 16 citations
5Supplementary Figure S8 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer2024
6Supplementary Figure S8 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer2024
7Abstract B064: Impact of germline pathogenic variants on pancreatic cancer screening and outcomes2025
8Supplementary Figure 4 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study2025